SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

VISTA PHARMACEUTICALS

BSE: 524711 09 Sep 2025
Healthcare
₹ 9.98
Vista Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

VISTA PHARMACEUTICALS - Share Price & Details

Market Cap
₹70.4
High /Low
16.6 / 9.1
Stock P/E
NA
Book Value
₹12.3
Dividend Yield
0.0
ROCE
-8.55
ROE
₹-10.8
Face Value
2.0
PEG Ratio
NA
EVEBITDA
₹-21.5
Debt
7.40
CMP / FCF
-13.1
Debt to equity
₹0.16
NP Ann
-4.65
High price all time
56.2
Piotroski score
₹3.0
Graham Number
NA
No. Eq. Shares
6.16
Net CF
₹0.64
Net profit
-4.65
Price to book value
0.93
Interest Coverage
₹-4.51
Low price all time
0.41
Industry PE
33.8
Reserves
₹33.1
Free Cash Flow
₹-7.42

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
FABINO ENTERPRISES LIMITEDNANANANA5.4691.0
Triochem Products Ltd.,NANANANA0
VISTA PHARMACEUTICALS LTD.NANANANA70.4
BIOFIL CHEMICALS & PHARMACEUTI92.6524.1164.331.4869.224.8
SHREE PACETRONIX LTD.NANANANA66.464.5

Peer Comparison Chart


About VISTA PHARMACEUTICALS

Vista Pharmaceuticals Ltd., with Security Code 524711, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Biotech KalVista Pharmaceuticals Awards 5,000 Share Stock Options Under Special Nasdaq Inducement Rule

(05 Sep 2025)
... & SALISBURY, England --(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the compensation committee...
Read more →

Biotech Update: KalVista Pharmaceuticals (KALV) Announces Q2 2025 Financial Results Date and Operations Review

(05 Sep 2025)
... & SALISBURY, England --(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the company will host a...
Read more →

Biotech Company KalVista Pharmaceuticals to Share Latest Developments at Major Healthcare Conference

(27 Aug 2025)
... & SALISBURY, England --(BUSINESS WIRE)-- KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today announced that the Company will participate in a fireside...
Read more →

Coromandel Engineering Company reports standalone net loss of Rs 0.73 crore in the June 2025 quarter

(18 Aug 2025)
Sales rise 13.03% to Rs 8.59 crore.
Read more →

Vista Pharmaceuticals reports standalone net loss of Rs 1.29 crore in the June 2025 quarter

(14 Aug 2025)
Net Loss of Vista Pharmaceuticals reported to Rs 1.29 crore in the quarter ended June 2025 as against net loss of Rs 0.86 crore during the previous quarter...
Read more →

Vista Pharmaceuticals Reports Stable Financial Performance Amid Evaluation Score Improvement in August 2025

(14 Aug 2025)
Vista Pharmaceuticals has announced its financial results for the quarter ending June 2025, revealing stable performance. An evaluation score adjustment...
Read more →

Company Updates